Pfizer Cautious on Pharma Tariffs
This is a U.S. news story, published by CNBC, that relates primarily to Albert Bourla news.
U.S. news
For more U.S. news, you can click here:
more U.S. newsAlbert Bourla news
For more Albert Bourla news, you can click here:
more Albert Bourla newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsCNBC news
For more news from CNBC, you can click here:
more news from CNBCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
pharmaceutical tariffs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Pfizer CEO Albert Bourla news, Pfizer executives news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
future tariffsCNBC
•Health
Health
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

77% Informative
Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Trump 's planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing.
Bourla 's remarks came in response to a question about what Pfizer wants to see from tariff negotiations.
Pfizer said it expects $150 million in costs from Trump 's existing tariffs this year .
VR Score
85
Informative language
89
Neutral language
72
Article tone
informal
Language
English
Language complexity
60
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links